World's first Ebola vaccine is green-lit by European drug regulators

sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more
World's first Ebola vaccine is green-lit by European drug regulators after it showed survival rates of 90% in a clinical trial in disease-hit Congo So-called Merk vaccine was approved on Friday afternoon and hailed as triumph It was already being used under emergency guidelines in Congo amid outbreak 

By Connor Boyd Health Reporter For Mailonline

Published: 15:34 BST, 18 October 2019 | Updated: 15:36 BST, 18 October 2019

View
comments

An Ebola vaccine has been approved by European drugs regulators in a move hailed as a 'triumph for public health'.

The so-called Merk vaccine was green lit this afternoon and is likely to get a full marketing licence from the European Commission within a few weeks.

It is already being used under emergency guidelines to try to halt the deadly outbreak currently ravaging the Democratic Republic of Congo.

The vaccine, developed by US drugmaker Merck & Co, is also being reviewed under a fast-track system by regulators in America.

An Ebola vaccine has been approved by European drugs regulators on Friday in what is being hailed as a 'triumph for public health'  (file)

An Ebola vaccine has been approved by European drugs regulators on Friday in what is being hailed as a 'triumph for public health'  (file)

The World Health Organization (WHO) said the advancement was a 'triumph for public

read more from dailymail.....

Get the latest news delivered to your inbox

Follow us on social media networks

NEXT Liver cancer deaths have increased by around 50% in the last decade